Showing results (261-270 of 472) with videos related to
Sort By:
Pageof 48
Cancer Investigation|February 15, 2011
Infusional mitoxantrone plus bolus melphalan as a stem cell transplant conditioning regimen for multiple myelomaAnne W Beaven, Dominic T Moore, Andrew Sharf, et al.Blood|December 24, 1998
Murine T lymphocytes incapable of producing macrophage inhibitory protein-1 are impaired in causing graft-versus-host disease across a class I but not class II major histocompatibility complex barrierJ S Serody, D N Cook, S L Kirby, et al.Cancer Treatment Reviews|January 1, 1993
High-dose carboplatin chemotherapy with GM-CSF and peripheral blood progenitor cell support: a model for delivering repeated cycles of dose-intensive therapyT C Shea, J R Mason, A M Storniolo, et al.Bone Marrow Transplantation|May 28, 2013
Allogeneic hematopoietic cell transplantation for diffuse large B cell lymphoma: who, when and how?E Klyuchnikov, U Bacher, T Kroll, et al.BJU International|March 24, 2009
The burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTSKarin S Coyne, Alan J Wein, Andrea Tubaro, et al.The Science of the Total Environment|April 11, 2021
Reactions of nitrite with goethite and surface Fe(II)-goethite complexesP Dhakal, M S Coyne, D H McNear, et al.Current Medical Research and Opinion|December 17, 2020
Establishing the content validity of the Prescription Opioid Misuse and Abuse Questionnaire (POMAQ) among chronic pain patientsKarin S Coyne, Alexandra I Barsdorf, Anne Brooks, et al.American Journal of Obstetrics and Gynecology|November 25, 2019
Achieving clinically meaningful response in endometriosis pain symptoms is associated with improvements in health-related quality of life and work productivity: analysis of 2 phase III clinical trialsRobin M Pokrzywinski, Ahmed M Soliman, Jun Chen, et al.Current Medical Research and Opinion|March 1, 2013
Prevalence of gastroprotective agent (GPA) use in adults with arthritis in the United StatesKarin S Coyne, Mary Kay Margolis, Joseph C Cappelleri, et al.American Heart Journal|August 2, 2001
A randomized trial confirming the efficacy of reduced dose recombinant tissue plasminogen activator in a Chinese myocardial infarction population and demonstrating superiority to usual dose urokinase: the TUCC trialA M Ross, R Gao, K S Coyne, et al.Pageof 48